Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | SRC | P12931 | 1/20 | 0.34 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL233123 | 1.00 | ALOX15 (0.52) | ALOX15TSHRALDH1A1USP2GLA | |
| SCHEMBL22111423 | 1.00 | ALOX15 (0.52) | ALOX15TSHRALDH1A1USP2GLA | |
| SCHEMBL23892698 | 1.00 | ALOX15 (0.52) | ALOX15TSHRALDH1A1USP2GLA | |
| SCHEMBL30886891 | 0.82 | ALOX15 (0.35) | ALOX15TSHRALDH1A1 | |
| SCHEMBL2006490 | 0.81 | ALOX15 (0.50) | ALOX15TSHRALDH1A1USP2GLA | |
| SCHEMBL6908214 | 0.78 | ALOX15 (0.47) | ALOX15TSHRALDH1A1USP2GLA | |
| SCHEMBL29785 | 0.77 | ALOX15 (0.55) | ALOX15TSHRALDH1A1USP2GLA | |
| SCHEMBL17242080 | 0.77 | ALOX15 (0.55) | ALOX15TSHRALDH1A1USP2GLA | |
| SCHEMBL17967768 | 0.77 | ALOX15 (0.55) | ALOX15TSHRALDH1A1USP2GLA | |
| SCHEMBL6444472 | 0.77 | ALDH1A1 (0.35) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109790092-B | 1-hydroxymethyl-1,2,2,6-tetramethyl-cyclohexane and derivatives thereof and their use as fragrance chemicals | 巴斯夫欧洲公司 | 2023-06-20 | — | — | CN | disclosed |
| EP-3494103-B1 | 1-HYDROXYMETHYL-1,2,2,6-TETRAMETHYL-CYCLOHEXANE AND DERIVATIVES THEREOF AND THEIR USE AS AROMA CHEMICALS | BASF SE (DE) | 2021-10-06 | — | — | EP | disclosed |
| EP-3494103-A1 | 1-HYDROXYMETHYL-1,2,2,6-TETRAMETHYL-CYCLOHEXANE AND DERIVATIVES THEREOF AND THEIR USE AS AROMA CHEMICALS | BASF SE (DE) | 2019-06-12 | — | — | EP | disclosed |
| US-20190169108-A1 | 1-HYDROXYMETHYL-1,2,2,6-TETRAMETHYL-CYCLOHEXANE AND DERIVATIVES THEREOF AND THEIR USE AS AROMA CHEMICALS | BASF CHEMICALS INDIA PVT. LTD. (IN) | 2019-06-06 | — | — | US | disclosed |
| CN-109790092-A | 1- methylol -1,2,2,6- tetramethyl-hexamethylene and its derivative and their purposes as aromachemicals | 巴斯夫欧洲公司 | 2019-05-21 | — | — | CN | disclosed |
| EP-2720539-B1 | OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE | BIKAM PHARMACEUTICALS INC (US) | 2018-10-24 | — | — | EP | disclosed |
| WO-2018024820-A1 | 1-HYDROXYMETHYL-1,2,2,6-TETRAMETHYL-CYCLOHEXANE AND DERIVATIVES THEREOF AND THEIR USE AS AROMA CHEMICALS | BASF SE (DE) | 2018-02-08 | — | — | WO | disclosed |
| CN-103917093-B | Opsin binding ligands, compositions, and methods of use | 比卡姆药品公司 | 2017-08-11 | — | — | CN | disclosed |
| CN-106431988-A | Opsin-binding ligands, compositions and methods of use | 比卡姆药品公司 | 2017-02-22 | — | — | CN | disclosed |
| US-20170037024-A1 | Opsin-Binding Ligands, Compositions and Methods for Use | BIKAM PHARMACEUTICALS, INC. (US) | 2017-02-09 | — | — | US | disclosed |
| US-9457004-B2 | Opsin-binding ligands, compositions and methods of use | BIKAM PHARMACEUTICALS INC. (US) | 2016-10-04 | — | — | US | disclosed |
| US-20150366834-A1 | Opsin-Binding Ligands, Compositions and Methods of Use | BIKAM PHARMACEUTICALS, INC. (US) | 2015-12-24 | — | — | US | disclosed |
| US-9133082-B2 | Opsin-binding ligands, compositions and methods of use | BIKAM PHARMACEUTICALS, INC. (US) | 2015-09-15 | — | — | US | disclosed |
| US-20140135374-A1 | Opsin-Binding Ligands, Compositions and Methods of Use | BIKAM PHARMACEUTICALS, INC. (US) | 2014-05-15 | — | — | US | disclosed |
| EP-2720539-A1 | OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE | Bikam Pharmaceuticals, Inc. (US) | 2014-04-23 | — | — | EP | disclosed |
| WO-2012174064-A1 | OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE | BIKAM PHARMACEUTICALS, INC. (US) | 2012-12-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140135374-A1 | Opsin-Binding Ligands, Compositions and Methods of Use | CRYAB, CRYAA, PDE6C | ALOX15 3081/4885TSHR 656/4885ALDH1A1 2166/4885 |
| US-20150366834-A1 | Opsin-Binding Ligands, Compositions and Methods of Use | CRYAB, CRYAA, PDE6C | ALOX15 3081/4885TSHR 656/4885ALDH1A1 2166/4885 |
| US-20170037024-A1 | Opsin-Binding Ligands, Compositions and Methods for Use | CRYAB, CRYAA, PDE6C | ALOX15 3055/4885TSHR 746/4885ALDH1A1 2191/4885 |
| US-20190169108-A1 | 1-HYDROXYMETHYL-1,2,2,6-TETRAMETHYL-CYCLOHEXANE AND DERIVATIVES THEREOF AND THEIR USE AS AROMA CHEMICALS | TMT1A, CYP19A1, CYP51A1 | ALOX15 603/4885TSHR 3508/4885ALDH1A1 13/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.